3 Steps to DSCSA Readiness in Q3: Strengthen Your Compliance Strategy Before It’s Tested

With DSCSA enforcement now in effect for manufacturers and the distributor deadline just weeks away, the pharmaceutical industry has officially entered the home stretch and a new era of supply chain accountability. From serialized data exchange to real-time traceability and trading partner verification, compliance is no longer a future goal—it’s a daily operational reality.

For manufacturers, wholesalers, and healthcare providers, Q3 is a critical time to reinforce your systems, streamline processes, and ensure you're fully equipped to operate under DSCSA requirements. The good news? If you're not quite there yet, there's still time to close gaps and build confidence in your compliance.

At LSPedia, we've distilled readiness into three essential steps that make a measurable impact across your operation:

1. Confirm EPCIS Connections with All Trading Partners

Now that EPCIS is the standard for exchanging serialized data, seamless connectivity with all your authorized trading partners is non-negotiable. EPCIS enables the secure, standardized communication of product movements and ownership changes, ensuring traceability throughout the supply chain.

Key actions to take this quarter:

• Verify that all EPCIS connections are live, tested, and compliant.

• Monitor transaction success rates to ensure consistent data flow.

• Identify and resolve any formatting, mapping, or system integration issues.

Delays in establishing or validating connections can quickly lead to shipment rejections, regulatory scrutiny, and supply chain breakdowns. Prioritizing EPCIS integrity now ensures uninterrupted product movement later.

2. Automate Exception Resolution to Keep Product Flowing

Even with EPCIS in place, exceptions still occur—data mismatches, verification failures, or missing product identifiers can disrupt the supply chain. If not resolved quickly, these issues put product availability, partner trust, and patient safety at risk.

Why automation matters now more than ever:

• Real-time alerts prevent bottlenecks before they stagnate.

• Guided workflows accelerate resolution and reduce manual errors.

• Exception trends can be analyzed and corrected at the root cause.

LSPedia’s OneScan Investigator platform simplifies this process by surfacing issues as they happen and directing users through compliant resolution paths. The result: faster turnaround, fewer disruptions, and stronger trading partner relationships.

3. Get Audit-Ready with Centralized Data and Real-Time Reporting

Under DSCSA, compliance isn’t just about having the right data—it’s about being able to prove it at a moment’s notice. Whether it's an FDA inquiry, a partner verification request, or an internal audit, your ability to access and report on serialized product data is key.

Readiness means being able to:

• Instantly trace a product’s full transaction history.

• Verify product legitimacy and trading partner authorization.

• Generate defensible audit reports from a single, centralized system.

With the right tools, audit readiness becomes routine—not reactive. OneScan’s compliance dashboards and reporting capabilities ensure that you're always prepared, no matter who’s asking.

Ready for What’s Next? We Are.

DSCSA compliance doesn’t have to be overwhelming. With the right platform and processes in place, you can turn regulatory pressure into a competitive advantage—boosting operational efficiency, supply chain resilience, and patient safety.

This quarter is your opportunity to pressure-test your systems, resolve lingering gaps, and lead with confidence.
Let’s make Q3 the turning point for your compliance strategy.

‍

Connect With Us